共 50 条
- [41] Correction: Wild-type and mutated IDH1/2 enzymes and therapy responsesOncogene, 2018, 37 : 5810 - 5810Remco J. MolenaarJaroslaw P. MaciejewskiJohanna W. WilminkCornelis J. F. van Noorden
- [42] MYELOID-ASSOCIATED WILD-TYPE IDH1 PROMOTES IMMUNOSUPPRESSION IN GLIOBLASTOMANEURO-ONCOLOGY, 2024, 26Dussold, CoreyTripathi, ShashwatMahajan, AkankshaTommasini-Ghelfi, SerenaHurley, LisaJarvis, RachelNajem, HindaChalastanis, AlexandraSooreshjani, MoloudDu, RuochenMccornack, ColinGiles, DavidTurunen, JillynBillingham, LeahKim, SeunghyunBroom, WendyDadali-Abel, TulinMurnan, KevinHorbinski, CraigThorp, EdwardKim, AlbertLi, YangMiska, JasonHeimberger, AmyStegh, Alexander
- [43] Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivoActa Neuropathologica, 2017, 133 : 629 - 644Stefan PuschSonja KrausertViktoria FischerJörg BalssMartina OttDaniel SchrimpfDavid CapperFelix SahmJessica EiselAnn-Christin BeckManfred JugoldViktoria EichwaldStefan KaulfussOlaf PankninHartmut RehwinkelKatja ZimmermannRoman C. HilligJudith GuentherLuisella ToschiRoland NeuhausAndrea HaegebartHolger Hess-StumppMarkus BauserWolfgang WickAndreas UnterbergChristel Herold-MendeMichael PlattenAndreas von Deimling
- [44] Differential expression of the TWEAK receptor Fn14 in IDH1 wild-type and mutant gliomasJOURNAL OF NEURO-ONCOLOGY, 2018, 138 (02) : 241 - 250Hersh, David S.Peng, SenDancy, Jimena G.Galisteo, RebecaEschbacher, Jennifer M.Castellani, Rudy J.Heath, Jonathan E.Legesse, TekluKim, Anthony J.Woodworth, Graeme F.Tran, Nhan L.Winkles, Jeffrey A.
- [45] Mutant isocitrate dehydrogenase 1 (IDH1) inhibitor synergistically prolongs animal survival with standard therapies in patient-derived IDH1 mutant glioma xenograft mouse modelsCANCER RESEARCH, 2017, 77Kogiso, MariQi, LinZhang, HuiyuanBraun, Frank K.Du, YuchenHuang, YulunLindsay, HollyZhao, SiboInjac, Sarah G. G.Liu, ZhenBaxter, Patricia A.Su, Jack M.Perlaky, LaszloParsons, D. WilliamsChintagumpala, MuraliAdesina, AdekunleWang, JialiangSong, YongchengLi, Xiao-Nan
- [46] Multiscale, multimodal analysis of tumor heterogeneity in IDH1 mutant vs wild-type diffuse gliomasPLOS ONE, 2019, 14 (12):Berens, Michael E.Sood, AnupBarnholtz-Sloan, Jill S.Graf, John F.Cho, SangheeKim, SeungchanKiefer, JeffreyByron, Sara A.Halperin, Rebecca F.Nasser, SaraAdkins, JonathanCuyugan, LoriDevine, KarenOstrom, QuinnCouce, MartaWolansky, LeoMcDonough, ElizabethSchyberg, ShannonDinn, SeanSloan, Andrew E.Prados, MichaelPhillips, Joanna J.Nelson, Sarah J.Liang, Winnie S.Al-Kofahi, YousefRusu, MirabelaZavodszky, Maria, IGinty, Fiona
- [47] Differential expression of the TWEAK receptor Fn14 in IDH1 wild-type and mutant gliomasJournal of Neuro-Oncology, 2018, 138 : 241 - 250David S. HershSen PengJimena G. DancyRebeca GalisteoJennifer M. EschbacherRudy J. CastellaniJonathan E. HeathTeklu LegesseAnthony J. KimGraeme F. WoodworthNhan L. TranJeffrey A. Winkles
- [48] Wild-type IDH1 inhibition enhances chemotherapy response in pancreatic cancerCANCER RESEARCH, 2024, 84 (02)Zarei, MehrdadHajihassani, OmidHue, Jonathan J.Graor, Hallie J.Loftus, Alexander W.Rothermel, Luke D.Winter, Jordan M.
- [49] Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivoACTA NEUROPATHOLOGICA, 2017, 133 (04) : 629 - 644Pusch, StefanKrausert, SonjaFischer, ViktoriaBalss, JoergOtt, MartinaSchrimpf, DanielCapper, DavidSahm, FelixEisel, JessicaBeck, Ann-ChristinJugold, ManfredEichwald, ViktoriaKaulfuss, StefanPanknin, OlafRehwinkel, HartmutZimmermann, KatjaHillig, Roman C.Guenther, JudithToschi, LuisellaNeuhaus, RolandHaegebart, AndreaHess-Stumpp, HolgerBauser, MarkusWick, WolfgangUnterberg, AndreasHerold-Mende, ChristelPlatten, Michaelvon Deimling, Andreas
- [50] In silico gene expression analysis reveals glycolysis and acetate anaplerosis in IDH1 wild-type glioma and lactate and glutamate anaplerosis in IDH1-mutated gliomaONCOTARGET, 2017, 8 (30) : 49165 - 49177Khurshed, MohammedMolenaar, Remco J.Lenting, KrissieLeenders, William P.van Noorden, Cornelis J. F.